Statistical methods to assess the prognostic value of risk prediction rules in clinical research.


Journal

Aging clinical and experimental research
ISSN: 1720-8319
Titre abrégé: Aging Clin Exp Res
Pays: Germany
ID NLM: 101132995

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 07 02 2020
accepted: 24 03 2020
pubmed: 3 4 2020
medline: 3 3 2021
entrez: 3 4 2020
Statut: ppublish

Résumé

Prognosis aims at estimating the future course of a given disease in probabilistic terms. As in diagnosis, where clinicians are interested in knowing the accuracy of a new test to identify patients affected by a given disease, in prognosis they wish to accurately identify patients at risk of a future event conditional to one or more prognostic factors. Thus, accurate risk predictions play a primary role in all fields of clinical medicine and in geriatrics as well because they can help clinicians to tailor the intensity of a treatment and to schedule clinical surveillance according to the risk of the concerned patient. Statistical methods able to evaluate the prognostic accuracy of a risk score demand the assessment of discrimination (the Harrell's C-index), calibration (Hosmer-May test) and risk reclassification abilities (IDI, an index of risk reclassification) of the same risk prediction rule whereas, in spite of the popular belief that traditional statistical techniques providing relative measures of effect (such as the hazard ratio derived by Cox regression analysis or the odds ratio obtained by logistic regression analysis) could be per se enough to assess the prognostic value of a biomarker or of a risk score. In this paper we provide a brief theoretical background of each statistical test and a practical approach to the issue. For didactic purposes, in the paper we also provide a dataset (n = 40) to allow the reader to train in the application of the proposed statistical methods.

Identifiants

pubmed: 32240502
doi: 10.1007/s40520-020-01542-y
pii: 10.1007/s40520-020-01542-y
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

279-283

Références

Harrell FE Jr, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361–387
doi: 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4
Crowson CS, Atkinson EJ, Therneau TM (2016) Assessing calibration of prognostic risk scores. Stat Methods Med Res 25:1692–1706
doi: 10.1177/0962280213497434
Pencina MJ, D'Agostino RB Jr, D'Agostino RB Jr et al (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27:157–172
doi: 10.1002/sim.2929
Kerkmeijer LG, Monninkhof EM, van Oort IM et al (2016) PREDICT: model for prediction of survival in localized prostate cancer. World J Urol 34:789–795
doi: 10.1007/s00345-015-1691-4
Schmoor C, Sauerbrei W, Schumacher M (2000) Sample size considerations for the evaluation of prognostic factors in survival analysis. Stat Med 19:441–452
doi: 10.1002/(SICI)1097-0258(20000229)19:4<441::AID-SIM349>3.0.CO;2-N
Ash D, Flynn A, Battermann J et al (2000) ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother Oncol 57:315–321
doi: 10.1016/S0167-8140(00)00306-6
Tripepi G, Heinze G, Jager KJ et al (2013) Risk prediction models. Nephrol Dial Transplant 28:1975–1980
doi: 10.1093/ndt/gft095

Auteurs

Graziella D'Arrigo (G)

Institute of Clinical Physiology (IFC-CNR), Clinical Epidemiology and Physiopathology of Renal Diseases and Hypertension of Reggio Calabria, Ospedali Riuniti, Via Vallone Petrara snc, Reggio Calabria, Italy.

Mercedes Gori (M)

Institute of Clinical Physiology (IFC-CNR), Rome, Italy.

Annalisa Pitino (A)

Institute of Clinical Physiology (IFC-CNR), Rome, Italy.

Claudia Torino (C)

Institute of Clinical Physiology (IFC-CNR), Clinical Epidemiology and Physiopathology of Renal Diseases and Hypertension of Reggio Calabria, Ospedali Riuniti, Via Vallone Petrara snc, Reggio Calabria, Italy.

Stefanos Roumeliotis (S)

Institute of Clinical Physiology (IFC-CNR), Clinical Epidemiology and Physiopathology of Renal Diseases and Hypertension of Reggio Calabria, Ospedali Riuniti, Via Vallone Petrara snc, Reggio Calabria, Italy.
Division of Nephrology and Hypertension, 1st Department of Internal Medicine, AHEPA Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Giovanni Tripepi (G)

Institute of Clinical Physiology (IFC-CNR), Clinical Epidemiology and Physiopathology of Renal Diseases and Hypertension of Reggio Calabria, Ospedali Riuniti, Via Vallone Petrara snc, Reggio Calabria, Italy. gtripepi@ifc.cnr.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH